MX2012014799A - Medicinal composition, preparation method and use thereof. - Google Patents
Medicinal composition, preparation method and use thereof.Info
- Publication number
- MX2012014799A MX2012014799A MX2012014799A MX2012014799A MX2012014799A MX 2012014799 A MX2012014799 A MX 2012014799A MX 2012014799 A MX2012014799 A MX 2012014799A MX 2012014799 A MX2012014799 A MX 2012014799A MX 2012014799 A MX2012014799 A MX 2012014799A
- Authority
- MX
- Mexico
- Prior art keywords
- medicinal composition
- preparation
- describes
- cough
- fruits
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 206010011224 Cough Diseases 0.000 abstract 1
- 241000282414 Homo sapiens Species 0.000 abstract 1
- 240000009134 Physalis philadelphica Species 0.000 abstract 1
- 235000002489 Physalis philadelphica Nutrition 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention describes a medicinal composition based on Physalis ixocarpa fruits, which is obtained by the inventive method. The invention also describes the use of said medicinal composition in the manufacture of drugs for treating airways diseases or disorders in human beings, relieving particular symptoms such as cough.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2012014799A MX2012014799A (en) | 2012-12-14 | 2012-12-14 | Medicinal composition, preparation method and use thereof. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2012014799A MX2012014799A (en) | 2012-12-14 | 2012-12-14 | Medicinal composition, preparation method and use thereof. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2012014799A true MX2012014799A (en) | 2014-06-25 |
Family
ID=51795988
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2012014799A MX2012014799A (en) | 2012-12-14 | 2012-12-14 | Medicinal composition, preparation method and use thereof. |
Country Status (1)
| Country | Link |
|---|---|
| MX (1) | MX2012014799A (en) |
-
2012
- 2012-12-14 MX MX2012014799A patent/MX2012014799A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202202711B (en) | Sustained-release dosage forms of ruxolitinib | |
| ZA202004764B (en) | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof | |
| HK1243922A1 (en) | Aadc polynucleotides for the treatment of parkinson's disease | |
| TN2015000434A1 (en) | Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders | |
| MX2022004103A (en) | An inhalable rapamycin formulation for treating age-related conditions. | |
| JO3199B1 (en) | Substituted 5-fluoro-1H-pyrazolopyridines and their use | |
| PH12015500106B1 (en) | Novel 5-aminotetrahydroquinoline-2-carboxylic acids and use thereof | |
| SG10201808102WA (en) | Bicyclic heterocycle compounds and their uses in therapy | |
| WO2014152029A3 (en) | Oxazolo[5,4-c]quinolin-2-one compounds as bromodomain inhibitors | |
| AU2012253757A8 (en) | Partially saturated tricyclic compounds and methods of making and using same | |
| MX386256B (en) | C4-MODIFIED OLEANOLIC ACID DERIVATIVES FOR IL-17 INHIBITION AND OTHER USES. | |
| PH12016500065A1 (en) | Benzyl-1h-pyrazolo[3,4-b]pyridines and use thereof | |
| HK1217092A1 (en) | Therapeutic compounds and uses thereof | |
| PH12016501968A1 (en) | Novel macrocyclic compounds | |
| GB201213484D0 (en) | Pharmaceutical compositions comprising 15-OHEPA and methods of using the same | |
| PH12016500608A1 (en) | Cyclic thienouracil-carboxamides and use thereof | |
| MX2015005732A (en) | Tricyclic compounds and methods of making and using same. | |
| MX2015005111A (en) | Herbal composition for the prevention and treatment of tnf-î± mediated diseases. | |
| MX2015005733A (en) | Tricyclic compounds for use in the treatment and/or control of obesity. | |
| MX2013002261A (en) | Substituted n-phenethyltriazoloneacetamides and use thereof. | |
| MX381932B (en) | INTRANASAL COMPOSITION INCLUDING BETAHISTINE. | |
| HK1202868A1 (en) | Carboxamide-substituted heteroaryl-pyrazoles and the use thereof | |
| WO2013038200A3 (en) | Neurodevelopmental disorders | |
| MX2012014799A (en) | Medicinal composition, preparation method and use thereof. | |
| PH12019501070A1 (en) | Sustained-release dosage forms of ruxolitinib |